Skip to Content
Merck
  • Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.

Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.

Bioorganic & medicinal chemistry letters (2007-04-27)
Mahbub Alam, Rebekah E Beevers, Tom Ceska, Richard J Davenport, Karen M Dickson, Mara Fortunato, Lewis Gowers, Alan F Haughan, Lynwen A James, Mark W Jones, Natasha Kinsella, Christopher Lowe, Johannes W G Meissner, Anne-Lise Nicolas, Benjamin G Perry, David J Phillips, William R Pitt, Adam Platt, Andrew J Ratcliffe, Andrew Sharpe, Laura J Tait
ABSTRACT

The development of a series of novel aminopyrimidines as inhibitors of c-Jun N-terminal kinases is described. The synthesis, in vitro inhibitory values for JNK1, JNK2 and CDK2, and the in vitro inhibitory value for a c-Jun cellular assay are discussed.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2,4-Dichloropyrimidine, 98%